Predictors of small-for-gestational-age infants in gestational diabetes mellitus: the impact of metformin use
Metformin use in GDMA2 pregnancies may be linked to SGA neonates. The impact of metformin on fetal growth highlights the need for careful monitoring and individualized treatment strategies in managing GDMA2.
Authors
- Sivan Farladansky‐Gershnabel
- Michal Kovo (ORCID: https://orcid.org/0000-0002-5443-5670)
- Tal Biron‐Shental (ORCID: https://orcid.org/0000-0003-4665-7051)
- Dorit Ravid (ORCID: https://orcid.org/0000-0003-0731-7660)
- Rosalyn Ram
- Dina Lidsky-Sachs
- Nur Abd El Qadir
Institutions
- Tel Aviv University (IL)
- Meir Medical Center (IL)
Publication Details
- Journal
- Archives of Gynecology and Obstetrics
- Published
- 2025-04-21
- DOI
- https://doi.org/10.1007/s00404-025-08029-z
- Citations
- 1
- Primary Topic
- Gestational Diabetes Research and Management
- Type
- article
- Field-Weighted Citation Impact
- 2.06
Funders
- Tel Aviv University